Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE 3rd, et al
Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne J-P, Frohman LA
Ipamorelin, when combined with either, provides milder, more targeted growth hormone release with fewer side effects
Women aged 25-45 with BMIs between 25-28 kg/m were randomly assigned to one of two groups: [5] Supresa group: 176.5 mg of standardized saffron extract daily (split into two doses) Placebo group: Identical-looking capsules with no active ingredients A key point that differentiates this study from many weight loss trials is that participants were not placed on any caloric restrictions